|
- 2016
低氧诱导因子在肝肺综合征大鼠肺组织中的表达及其与糖调节蛋白78的关系
|
Abstract:
摘要:目的 探讨低氧诱导因子-1α(HIF-1α)在大鼠肝肺综合征(HPS)发病中的作用及其与糖调节蛋白78(GRP78)的关系。方法 复合致病因素法制备HPS大鼠模型。Western blotting法检测肺组织HIF-1α、血管内皮生长因子164(VEGF164)及GRP78蛋白表达水平。免疫组化染色法观察肺组织VEGF受体2(VEGFR-2)及CD105的表达。结果 模型组动物肺组织HIF-1α蛋白表达水平在第8周显著高于同期正常对照组及4周、6周组;GRP78蛋白表达随病程进展逐渐升高,至第8周达到最高水平,各时间点之间以及与同期正常对照组比较差异均具有统计学意义;VEGF164蛋白表达随病程进展逐渐增加,至6周达到高峰,各时间点均显著高于同期正常对照组,6周和8周表达水平显著高于4周;VEGFR-2及CD105免疫组化染色强度和数量均随HPS进展逐渐增高;GRP78分别与VEGF164、VEGFR-2及CD105的表达水平呈正相关(P<0.05),HIF-1α与GRP78亦呈正相关关系(P<0.05)。结论 HIF-1α可能在HPS发病中起一定作用,与GRP78共同促进了肺微血管重构。
ABSTRACT: Objective To explore the role of HIF-1α in the pathogenesis of hepatopulmonary syndrome(HPS) and its relationship with GRP78. Methods The HPS model in rats was induced by multiple pathogenic factor. The samples were assessed by using Western blotting analysis for HIF-lα, GRP78 and VEGF164. The expressions of VEGFR-2 and CD105 were observed by using immunohistochemical staining. Results The protein level of HIF-1α was significantly increased in HPS group at week 8 compared with that at week 4 and 6 groups and corresponding normal control groups. With the development of HPS, protein level of GRP78 was gradually increased at each time point significantly and reached the highest level at week 8; protein level of VEGF164 showed a similar change with GRP78, but the peak was at week 6. Immunohistochemical results showed that the protein expressions of VEGFR-2 and CD105 were gradually increased in lung tissue as HPS progressed. The protein level of GRP78 was positively correlated with HIF-1α, VEGF164, VEGFR-2 and CD105, respectively (P<0.05). Conclusion HIF-1α is most likely together with GRP78 to play a critical role in promoting pulmonary microvascular remodeling in the pathogenesis of HPS in rats
[1] | AHLUWALIA A, S TARNAWSKI A. Critical role of hypoxia sensor-HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing[J]. Curr Med Chem, 2012, 19(1):90-97. |
[2] | LIANG WC, WU X, PEALE FV, et al. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF[J]. J Biol Chem, 2006, 281(2):951-961. |
[3] | REY S, SEMENZA GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodeling[J]. Cardiovasc Res, 2010, 86(2):236-242. |
[4] | BERRA E, PAGES G, POUYSSEGUR J. MAP kinases and hypoxia in the control of VEGF expression[J]. Cancer Metastasis Rev, 2000, 19(1-2):139-145. |
[5] | CLAESSON-WELSH L, WELSH M. VEGFA and tumor angiogenesis[J]. J Intern Med, 2013, 273(2):114-127. |
[6] | DALLAS NA, SAMUEL S, XIA L, et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy[J]. Clin Cancer Res, 2008, 14(7):1931-1937. |
[7] | SEMENZA GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology[J]. Annu Rev Pathol, 2014, 9:47-71. |
[8] | 刘衡,戴天阳. HIF-1与肺癌关系研究新进展[J]. 医学综述, 2012, 18(23):3957-3959. |
[9] | GORDAN JD, SIMON MC. Hypoxia-inducible factors: central regulators of the tumor phenotype[J]. Curr Opin Genet Dev, 2007, 17(1):71-77. |
[10] | ZHANG HY, HAN DW, WANG XG, et al. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome[J]. World J Gastroenterol, 2005, 11(4):567-572. |
[11] | ZHANG H, LV M, ZHAO Z, et al. Glucose-regulated protein 78 may play a crucial role in promoting the pulmonary microvascular remodeling in a rat model of hepatopulmonary syndrome[J]. Gene, 2014, 545(1):156-162. |
[12] | ZHANG HY, HAN DW, ZHAO ZF, et al. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia[J]. World J Gastroenterol, 2007, 13(25):3500-3507. |
[13] | 李晶,王勤涛. 血管内皮生长因子在牙周组织中的表达及其作用[J]. 国际口腔医学杂志, 2014, 41(4):455-458. |
[14] | SICA G, LAMA G, ANILE C, et al. Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma[J]. Int J Oncol, 2011, 38(1):41-49. |
[15] | ZHANG HY, HAN DW, SU AR, et al. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors[J]. World J Gastroenterol, 2007, 13(47):6385-6395. |
[16] | 戴淼,黄芸. CD105 在动脉粥样硬化血管新生中的研究进展[J]. 中华老年多器官疾病杂志, 2013, 12(11):868-870. |
[17] | CLARA CA, MARIE SK, DE ALMEIDA JR, et al. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma[J]. Neuropathology, 2014, 34(4):343-352. |
[18] | 邱亚双,周慧芳. HIF-1α和VEGF在喉癌中的表达及其与血管生成的关系[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(6):389-393. |
[19] | LEE SH, LEE SH, KIM CH, et al. Increased expression of vascular endothelial growth factor and hypoxia inducible factor-1α in lung tissue of patients with chronic bronchitis[J]. Clin Biochem, 2014, 47(7):552-559. |
[20] | KUO LJ, HUNG CS, CHEN WY, et al. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth[J]. J Surg Res, 2013, 185(1):264-272. |
[21] | NISHI K, ODA T, TAKABUCHI S, et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner[J]. Antioxid Redox Signal, 2008, 10(5):983-996. |
[22] | NICHOLAS SA, SUMBAYEV VV. The role of redox-dependent mechanisms in the downregulation of ligand-induced Toll-like receptors 7, 8 and 4-mediated HIF-1α prolyl hydroxylation[J]. Immunol Cell Biol, 2010, 88(2):180-186. |
[23] | PEREIRA ER, FRUDD K, AWAD W, et al. Endoplasmic reticulum (ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF)[J]. J Biol Chem, 2014, 289(6):3352-3364. |
[24] | KWON SJ, SONG JJ, LEE YJ. Signal pathway of hypoxia-inducible factor-1α phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells[J]. Clin Cancer, 2005, 11(21):7607-7613. |